Evidence map›Paper›PMID 38389881›Full record

ReviewRSC medicinal chemistry2024

Research progress of metal-organic framework nanozymes in bacterial sensing, detection, and treatment.

Yiwei An, Xuankun Fang, Jie Cheng, Shuiyuan Yang, Zuanguang Chen, Yanli Tong

Abstract readReview
In one paragraph

Review in RSC medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yiwei AnSchool of Pharmacy, Guangdong Medical University Dongguan 523808 China tongh2008@126.com.
Xuankun FangSchool of Pharmacy, Guangdong Medical University Dongguan 523808 China tongh2008@126.com.
Jie ChengSchool of Pharmaceutical Sciences, SunYat-sen University Guangzhou 510006 China chenzg@mail.sysu.edu.cn +86 20 39943071 +86 20 39943044.
Shuiyuan YangGuangdong Second Provincial General Hospital Guangzhou 510317 China.
Zuanguang ChenSchool of Pharmaceutical Sciences, SunYat-sen University Guangzhou 510006 China chenzg@mail.sysu.edu.cn +86 20 39943071 +86 20 39943044.ORCID https://orcid.org/0000-0002-9602-6381
Yanli TongSchool of Pharmacy, Guangdong Medical University Dongguan 523808 China tongh2008@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high efficiency and specificity of enzymes make them play an important role in life activities, but the high cost, low stability and high sensitivity of natural enzymes severely restrict their application. In recent years, nanozymes have become convincing alternatives to natural enzymes, finding utility across diverse domains, including biosensing, antibacterial interventions, cancer treatment, and environmental preservation. Nanozymes are characterized by their remarkable attributes, encompassing high stability, cost-effectiveness and robust catalytic activity. Within the contemporary scientific landscape, metal-organic frameworks (MOFs) have garnered considerable attention, primarily due to their versatile applications, spanning catalysis. Notably, MOFs serve as scaffolds for the development of nanozymes, particularly in the context of bacterial detection and treatment. This paper presents a comprehensive review of recent literature pertaining to MOFs and their pivotal role in bacterial detection and treatment. We explored the limitations and prospects for the development of MOF-based nanozymes as a platform for bacterial detection and therapy, and anticipate their great potential and broader clinical applications in addressing medical challenges.

Identifiers

PMID38389881
PMCPMC10880901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.